imipenem, anhydrous has been researched along with Pulmonary Disease, Chronic Obstructive in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, JL; Gu, DQ; Liu, PY; Sun, YX | 1 |
| Gunasekaran, J; Shariff, M | 1 |
| Cizmeci, Z; Dereli, N; Günay, E; Küçükbayrak, A; Uğurman, F | 1 |
| Xiang, XD; Yang, H; Yi, ZM | 1 |
| Amato, G; Bariffi, F; Giacomelli, P; Nani, E; Sanduzzi, A | 1 |
| Ding, X; Hu, S; Nie, H; Peng, Y; Wu, X | 1 |
| De Rose, V; Pozzi, E | 1 |
1 review(s) available for imipenem, anhydrous and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Imipenem in acute lung infections and bacterial re-exacerbations of chronic obstructive lung disease.
Topics: Acute Disease; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Thienamycins | 1991 |
6 other study(ies) available for imipenem, anhydrous and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
[Drug resistance of imipenem-resistant Gram-negative bacilli in coal worker's pneumoconiosis chronic obstructive pulmonary disease patients with lower respiratory tract infection].
Topics: Aged; Aged, 80 and over; Anthracosis; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2013 |
Pulmonary Nocardiosis: Review of Cases and an Update.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cough; Diabetes Mellitus; Dyspnea; Female; Humans; Imipenem; Immunocompromised Host; India; Male; Meropenem; Middle Aged; Nocardia Infections; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary | 2016 |
[A community acquired pneumonia case caused by Ralstonia pickettii].
Topics: Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Community-Acquired Infections; Drug Combinations; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Opportunistic Infections; Pneumonia, Bacterial; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Ralstonia pickettii; Treatment Outcome | 2009 |
[Characteristics of bacteriology and drug sensitivity in patients with COPD combined with pneumonia].
Topics: Adult; Aged; Amikacin; Bacteria; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Vancomycin | 2003 |
Imipenem/cilastatin as monotherapy in the treatment of acute or chronic lung infections: clinical efficacy and safety.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pulmonary Disease, Chronic Obstructive; Safety | 1989 |
Risk factors of superinfection following imipenem/cilastatin therapy in hospitalised patients with acute exacerbations of severe chronic obstructive pulmonary disease.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Cilastatin; Critical Care; Drug Combinations; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Protease Inhibitors; Pulmonary Disease, Chronic Obstructive; Regression Analysis; Risk Factors; Superinfection | 2006 |